Equine YKL-40 antibody and antigen (recombinant protein)
Diagnostic anti-Equine YKL-40 antibodies pairs and antigen for animal health (animal Equine/Horse Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-YKL-40-Ag01 | Recombinant Equine YKL-40 protein | 3090 |
GMP-EQU-YKL-40-Ab01 | Anti-Equine YKL-40 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-YKL-40-Ab02 | Anti-Equine YKL-40 mouse monoclonal antibody (mAb) | 1953 |
GMP-EQU-YKL-40-Ab03 | Anti-Equine YKL-40 human monoclonal antibody (mAb) | 1953 |
GMP-EQU-YKL-40-Ab04 | Anti-Equine YKL-40 human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-EQU-YKL-40-Ag01 |
Product Name | Recombinant Equine YKL-40 protein |
Target/Biomarker | Equine Chitinase-3-like protein 1 (YKL-40) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine Chitinase-3-like protein 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in YKL-40 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | His |
Products description | Recombinant Equine YKL-40 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-YKL-40-Ab01, GMP-EQU-YKL-40-Ab02 |
Product Name | Anti-Equine YKL-40 mouse monoclonal antibody (mAb) |
Target/Biomarker | Equine Chitinase-3-like protein 1 (YKL-40) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine Chitinase-3-like protein 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-YKL-40 antibodies in YKL-40 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | mFc |
Products description | Anti-Equine YKL-40 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-YKL-40 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-EQU-YKL-40-Ab03, GMP-EQU-YKL-40-Ab04 |
Product Name | Anti-Equine YKL-40 human monoclonal antibody (mAb) |
Target/Biomarker | Equine Chitinase-3-like protein 1 (YKL-40) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Equine Chitinase-3-like protein 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-YKL-40 antibodies in YKL-40 level test of animal Equine/Horse with Alzheimer Disease(AD). |
Tag | hFc |
Products description | Anti-Equine YKL-40 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-YKL-40 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Equine YKL-40, a glycoprotein with a molecular weight of approximately 40 kDa, emerges as a captivating figure in the intricate realm of equine immune responses and tissue dynamics. While it bears structural resemblance to chitinases, it distinguishes itself by its absence of chitinase activity. Its presence is pervasive in various equine tissues, with prominent expression in the liver, kidneys, lungs, and immune cells. Structurally, Equine YKL-40 is characterized by its unique chitin-binding domain, which suggests involvement in tissue remodeling and repair. The glycosylation of this protein enhances its stability and modulates its functions, particularly within the context of inflammation. The regulation of Equine YKL-40 expression is tightly orchestrated, with immune cells, including macrophages and neutrophils, being significant contributors. These cells are activated in response to inflammatory cues, prompting YKL-40 production. This induction underscores its role as a pro-inflammatory mediator and a sentinel of immune system activation. Beyond its role in immune responses, Equine YKL-40 is intricately linked to tissue remodeling processes. In conditions characterized by tissue injury and repair, such as wound healing and fibrosis, YKL-40's interactions with fibroblasts and epithelial cells gain prominence. It appears to modulate cellular activities associated with extracellular matrix turnover and tissue restructuring.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.